Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+13.5%/yr
vs +38.3%/yr prior
5Y CAGR
+20.4%/yr
Recent deceleration
Acceleration
-24.8pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $152.32M | -0.5% |
| 2024 | $153.02M | +43.1% |
| 2023 | $106.92M | +2.7% |
| 2022 | $104.10M | +24.4% |
| 2021 | $83.66M | +39.0% |
| 2020 | $60.21M | +47.4% |
| 2019 | $40.85M | +43.7% |
| 2018 | $28.43M | +33.7% |
| 2017 | $21.26M | +23.6% |
| 2016 | $17.20M | - |